Vistagen Therapeutics, Inc.

Pharmaceutical company · South San Francisco, California, United States · Nasdaq: VTGN

Vistagen Therapeutics, Inc. is a pharmaceutical company headquartered in South San Francisco, California, United States. Its shares trade on Nasdaq under the ticker VTGN. It has received 9 US government small-business research awards (SBIR/STTR) from health agencies, $7.2 million in total, most recently in 2009. It has reported private securities offerings to the US SEC, most recently $2.8 million sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

Vistagen Therapeutics at a glance

Typepharmaceutical company
HeadquartersSouth San Francisco, California, United States
Stock listingNasdaq: VTGN
SEC industryPharmaceutical Preparations
SEC CIK1411685

What does Vistagen Therapeutics do?

US government research funding

9 SBIR/STTR small-business research awards from US health agencies, $7.2 million in total (2000 to 2009).

Private fundraising reported to the SEC

8 Form D notices; the most recent reported $2.8 million sold (2020).

Frequently asked questions about Vistagen Therapeutics

Where is Vistagen Therapeutics headquartered?

Vistagen Therapeutics, Inc. is headquartered in South San Francisco, California, United States.

What does Vistagen Therapeutics do?

Vistagen Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Vistagen Therapeutics a public company?

Yes. Vistagen Therapeutics, Inc. trades on Nasdaq under the ticker VTGN.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.